Idiopathic intracranial hypertension in cystinosis

Journal of Pediatrics

Volumn 145, Issue 5, 2004, Pages 673-678

  Dogulu, Cigdem F ^a,b   Tsilou, Ekaterini ^a   Rubin, Benjamin ^a   FitzGibbon, Edmond J ^a   Kaiser Kupper, Muriel I ^a   Rennert, Owen M ^a   Gahl, William A ^a  

^a Natl Inst Child Hlth and Devmt   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIHYPERTENSIVE AGENT; ATENOLOL; ATORVASTATIN; AZATHIOPRINE; CHLOROTHIAZIDE; CYCLOSPORIN; DILTIAZEM; ENALAPRIL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FUROSEMIDE; GROWTH HORMONE; IMMUNOSUPPRESSIVE AGENT; LEVOTHYROXINE; MERCAPTAMINE; NIFEDIPINE; ORAL CONTRACEPTIVE AGENT; PHOSPHORUS; PRAZOSIN; PREDNISONE; SPIRONOLACTONE; TACROLIMUS; VERAPAMIL; VITAMIN D;

ADOLESCENT; ADULT; BRAIN; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID PRESSURE; CHILD; CLINICAL FEATURE; CYSTINOSIS; DYSMENORRHEA; FEMALE; HUMAN; HYPOTHYROIDISM; INTRACRANIAL HYPERTENSION; KIDNEY GRAFT; LITERATURE; MALE; MENORRHAGIA; NEUROIMAGING; PAPILLEDEMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SIDE EFFECT;

EID: 7444266845     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.06.080     Document Type: Article

References (48)

1. W.A. Gahl, J.G. Thoene, and J.A. Schneider Cystinosis N Engl J Med 347 2002 111 121
2. W.A. Gahl, N. Bashan, F. Tietze, I. Bernardini, and J.D. Schulman Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis Science 217 1982 1263 1265
3. W.A. Gahl, J.G. Thoene, and J.A. Schneider Cystinosis: a disorder of lysosomal membrane transport C. Scriver A. Beaudet W. Sly The metabolic and molecular bases of inherited disease 2001 McGraw-Hill New York 5085 5108
4. M. Kaiser-Kupfer, R. Caruso, D. Minkler, and W.A. Gahl Long-term ocular manifestations in nephropathic cystinosis Arch Ophthalmol 104 1986 706 711
5. W.A. Gahl, and M.I. Kaiser-Kupfer Complications of nephropathic cystinosis after renal failure Pediatr Nephrol 1 1987 260 268
6. W.A. Gahl, M. Dalakas, L. Charnas, K.T.K. Chen, G.H. Pezeshkpour, and T. Kuwabara Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis New Engl J Med 319 1988 1461 1464
7. B. Fivush, O.C. Green, C.C. Porter, J.W. Balfe, S. O'Regan, and W.A. Gahl Pancreatic endocrine insufficiency in posttransplant cystinosis Am J Dis Child 141 1987 1087 1089
8. B. Fivush, J.A. Flick, and W.A. Gahl Pancreatic exocrine insufficiency in a patient with nephropathic cystinosis J Pediatr 112 1988 49 51
9. B. Sonies, E.F. Ekman, H. Andersson, M. Adamson, S. Kaler, and T. Markello Swallowing dysfunction in nephropathic cystinosis N Engl J Med 323 1990 565 570
10. Y. Anikster, F. Lacbawan, M. Brantly, B.L. Gochuico, N.A. Avila, and W. Travis Pulmonary dysfunction in adults with nephropathic cystinosis Chest 119 2001 394 401
11. C.L. Chik, A. Friedman, G.R. Merriam, and W.A. Gahl Pituitary-testicular function in nephropathic cystinosis Annals Intern Med 119 1993 568 575
12. W.A. Gahl Early oral cysteamine therapy for nephropathic cystinosis Eur J Pediatr 2003 (published online on November 11, 2003)
13. D.S. Theodoropoulos, D. Krasnewich, M.I. Kaiser-Kupfer, and W.A. Gahl Classical nephropathic cystinosis as an adult disease JAMA 270 1993 2200 2204
14. W.A. Gahl, G.F. Reed, J.G. Thoene, J.D. Schulman, W.B. Rizzo, and A.J. Jonas Cysteamine therapy for children with nephropathic cystinosis N Engl J Med 316 1987 971 977
15. V.E. Kimonis, J. Troendle, M.L. Yang, S.R. Rose, T.C. Markello, and W.A. Gahl Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis J Clin Endocrinol Metab 80 1995 3257 3261
16. T.C. Markello, I.M. Bernardini, and W.A. Gahl Improved renal function in children with cystinosis treated with cysteamine N Engl J Med 328 1993 1157 1162
17. D.L. Ross, C.F. Strife, R. Towbin, and K.E. Bove Nonabsorptive hydrocephalus associated with nephropathic cystinosis Neurology 32 1982 1330 1334
18. A.J. Jonas, S.B. Conley, R. Marshall, R.A. Johnson, M. Marks, and H. Rosenberg Nephropathic cystinosis with central nervous system involvement Am J Med 83 1987 966 970
19. J.K. Fink, P. Brouwers, N. Barton, M.H. Malekzadeh, S. Sato, and S. Hill Neurologic complications in long-standing nephropathic cystinosis Arch Neurol 46 1989 543 548
20. S.L. Nichols, G.A. Press, J.A. Schneider, and D.A. Trauner Cortical atrophy and cognitive performance in infantile nephropathic cystinosis Pediatr Neurol 6 1990 379 381
21. D.G. Vogel, M.H. Malekzadeh, M.E. Cornford, J.A. Schneider, W.D. Shields, and H.V. Vinters Central nervous system involvement in nephropathic cystinosis J Neuropathol Exp Neurol 49 1990 591 599
22. M. Broyer, M.J. Tete, G. Guest, J.P. Bertheleme, F. Labrousse, and M. Poisson Clinical polymorphisms of cystinosis encephalopathy: results of treatment with cysteamine J Inherit Metab Dis 19 1996 65 75
23. J.L. Smith Whence pseudotumor cerebri? J Clin Neuroophthalmol 5 1985 55 56
24. D. Grant Benign intracranial hypertension Arch Dis Childhood 46 1971 651 655
25. M. Wall, and D. George Idiopathic intracranial hypertension: a prospective study of 50 patients Brain 114 1991 155 180
26. N.R. Miller, and N.J. Newman Papilledema N.R. Miller N.J. Newman The essentials. Walsh and Hoyt's clinical neuro-ophthalmology 5th ed. 1999 Williams & Wilkins Baltimore (MD) 166 196
27. F.J. Durcan, J.J. Corbett, and M. Wall The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana Arch Neurol 45 1988 875 877
28. O.A. Cruz, S.G. Fogg, and G. Roper-Hall Pseudotumor cerebri associated with cyclosporine use Am J Ophthalmol 122 1996 436 437
29. C. Bulens, W.A. De Vries, and H. van Crevel Benign intracranial hypertension: a retrospective and follow-up study J Neurol Sci 40 1979 147 157
30. A.H. Rogers, G.L. Rogers, D.L. Bremer, and M.L. McGregor Pseudotumor cerebri in children receiving recombinant human growth hormone Ophthalmology 106 1999 1186 1189
31. A. Walker, and J. Adamkiewicz Pseudotumor cerebri associated with prolonged corticosteroid therapy: report of four cases JAMA 188 1964 779 784
32. Y. Amrani, F. Terriza, C. Moreno, and A. Casado Pseudotumor cerebri caused by vitamin excess due to intake of milk enriched with A and D vitamins Rev Neurol 24 1996 1304 1305 Letter
33. S. Raghavan, J. DiMartino-Nardi, P. Saenger, and B. Linder Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism J Pediatr 130 1997 478 480
34. M. Wall Idiopathic intracranial hypertension Neurol Clin 9 1991 73 95
35. D. Chang, G. Nagamoto, and W.E. Smith Benign intracranial hypertension and chronic renal failure Cleve Clin J Med 59 1992 419 422
36. T. Obeid, A. Awada, S. Huraib, K. Quadri, and S. Abu-Romeh Pseudotumor cerebri in renal transplant recipients: a diagnostic challenge J Nephrol 10 1997 258 260
37. P.J. Francis, S. Haywood, S. Rigden, D.M. Calver, and G. Clark Benign intracranial hypertension in children following renal transplantation Pediatr Nephrol 18 2003 1265 1269
38. L.F. Casserly, S.M. Reddy, and L.M. Dember Venous thromboembolism in end-stage renal disease Am J Kidney Dis 36 2000 405 411
39. A.G. Bostom, R.Y. Gohh, M.Y. Tsai, B.J. Hopkins-Garcia, M.R. Nadeau, and L.A. Bianchi Excess prevalance of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients Atheroscler Thromb Vasc Biol 17 1997 1894 1900
40. R. Marcucci, S. Fedi, T. Brunelli, G. Pepe, D. Prisco, and A. Rosati High cysteine levels in renal transplant patients Transplantation 71 2001 746 751
41. C.F. Dogulu, T. Kansu, M.Y.K. Leung, V. Baxendale, S.M. Wu, M. Ozguc, W.Y. Chan, and O.M. Rennert Evidence for genetic susceptibility to thrombosis in idiopathic intracranial hypertension Thrombosis Res 111 2003 389 395
42. G. Orefice, G. De Joanna, M. Coppola, V. Brancaccio, and P.R.J. Ames Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome? Lupus 4 1995 324 326
43. J. Sussman, M. Leach, M. Greaves, R. Malia, and G.A.B. Davies-Jones Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension J Neurol Neurosurg Psychiatry 62 1997 229 233
44. O. Backhouse, T. Metcalfe, P. Goulding, M. McEvoy, and M. Menage Factor V Leiden mutation in association with idiopathic intracranial hypertension Br J Ophthalmol 82 1998 844 Letter
45. V.P. Calabrese, J.B. Selhorst, and J.W. Harbison CSF infusion test in pseudotumor cerebri Trans Am Neurol Assoc 03 1978 146 150
46. F. Gjerris, P. Soelberg Sorensen, S. Vorstrup, and O.B. Paulson Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri) Ann Neurol 17 1985 158 162
47. J. Malm, B. Kristensen, P. Markgren, and J. Ekstedt CSF hydrodynamics in idiopathic intracranial hypertension: a long-term study Neurology 42 1992 851 858
48. M. Park, A. Helip-Wooley, and J. Thoene Lysosomal cysteine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells J Am Soc Nephrol 13 2002 2878 2887